Japan ordered to pay for tainted blood
A court in Tokyo ordered the Japanese government and three drug makers Friday to pay damages to people who contracted hepatitis C from tainted blood products.Comment
topix.net 1h and 17m ago

Hepatitis - Topix.net
News on Hepatitis continually updated from thousands of sources around the net.
topix.net 1h and 17m ago

St. Joseph's General Hospital
Health officials push Albertans to question safety of province's medical facilities Visiting at St.Joseph's General Hospital in Vegreville has been restricted because of the outbreak of a bacterial-resistant ...Comment
topix.net Thu, 22 Mar 2007 13:36:11 GMT

The American Liver Foundation Urges Cautious Optimism About CDC Report On Declining Acute Hepatitis Infection Rates
The Centers for Disease Control and Prevention (CDC) has reported that significant decline in the rates of new acute hepatitis infections in the United States in the last 10 years, reflecting the success of hepatitis A and B vaccination programs.
Medicalnewstoday.com Thu, 22 Mar 2007 00:00:00 PDT

Cancer Guidelines Recommend Posaconazole for Preventing Invasive Fungal Infections
Schering-Plough Corporation today reported that its antifungal agent NOXAFIL Oral Suspension received a category 1 recommendation for preventing certain invasive fungal infections in high-risk cancer patients ...Comment
topix.net Wed, 21 Mar 2007 17:11:39 GMT

Vegreville hospital issues alert over superbug
A rural Alberta hospital has been ordered to stop taking new patients because of the spread of a so-called superbug and the discovery that hospital equipment wasn't properly sterilized for years.Comment
topix.net Tue, 20 Mar 2007 20:48:48 GMT

Alta. hospital closes doors over superbug spread
A rural Alberta hospital has been ordered to stop taking new patients while it deals with two serious issues: the outbreak of a potent superbug; and the discovery of improper equipment sterilization procedures.Comment
topix.net Tue, 20 Mar 2007 19:27:13 GMT

Intarcia restarts with $50M for hepatitis, diabetes treatments
Filed 03.20.07 in Venture Capital Intarcia , an Emeryville biopharma company developing treatments for hepatitis C and type 2 diabetes, said it has raised $50 million in round of financing to restart the ...Comment
topix.net Tue, 20 Mar 2007 16:18:18 GMT

Date set for NHS inquiry
A CAMPAIGNER who has battled for almost 20 years to discover why haemophilia sufferers became infected with HIV or hepatitis C is delighted a date for a formal inquiry into the tragedy has been set.Comment
topix.net Tue, 20 Mar 2007 03:47:41 GMT

Improving Diagnosis Of Tropical Diseases
Conditions in resource-limited countries pose unique challenges to developing affordable diagnostics Celia Henry Arnaud THE FIRST STEP in treating a disease is diagnosing it.Comment
topix.net Mon, 19 Mar 2007 16:58:52 GMT

Vaccinations -- they're worth a shot for adults
Immunity is your body's protection or resistance to a disease. Immunity can begin to fade over time.Comment
topix.net Mon, 19 Mar 2007 06:03:46 GMT

Police, fire and prison staff to get injections against Hepatitis B
POLICE and firefighters will be given a vaccination against Hepatitis B, as part of a number of new measures to protect frontline workers from blood-borne viruses.
Scotsman Wed, 14 Mar 2007 01:34:17 GMT

Sucampo Pharmaceuticals Initiates Post-Marketing Studies Of AMITIZA(R) In Subjects With Renal Or Hepatic Impairment
Sucampo Pharmaceuticals, Inc., today announced that it has begun two clinical studies of AMITIZA(R) (lubiprostone) in subjects with either renal or hepatic impairment. AMITIZA was approved by the U.S. Food and Drug Administration (FDA) in January 2006 for the treatment of Chronic Idiopathic Constipation in adults.
Medicalnewstoday.com Wed, 14 Mar 2007 00:00:00 PDT

Study Published In New England Journal Of Medicine: Vaccine 95.5% Effective Against Neglected Hepatitis E
A new candidate vaccine against hepatitis E, developed collaboratively by GlaxoSmithKline (GSK) and the Walter Reed Army Institute of Research (WRAIR), was found to be 95.5% effective in a Phase Two trial, according to a study to be published in the New England Journal of Medicine. Hepatitis E, a waterborne strain of hepatitis that occurs almost exclusively in the developing world, is currently without cure or medical prophylaxis. Three doses were administered over six months.
Medicalnewstoday.com Mon, 12 Mar 2007 00:00:00 PDT

New Culture System Leads To Anti-Viral Treatments For Hepatitis C
A new way of growing viruses in the laboratory developed by Japanese researchers could spell hope for the 170 million people infected with hepatitis C, only half of whom currently respond to drug treatments, scientists announced today (Tuesday 27 March 2007) at the Society for General Microbiology's 160th Meeting at the University of Manchester, UK, which will run from 26 29 March 2007.
Medicalnewstoday.com Sat, 10 Mar 2007 00:00:00 PDT

Outcomes For Patients With Hepatitis B Who Need Liver Transplants
Survival rates are similar among patients with hepatitis B who are listed for liver transplantation, whether or not they have hepatocellular carcinoma (HCC), according to a new study in the March 2007 issue of Liver Transplantation. An accompanying editorial suggests that these results affirm the current policy on the allocation of donor livers.
Medicalnewstoday.com Wed, 07 Mar 2007 18:00:00 PDT

Relatives in court battle for hepatitis C public inquiry
CAMPAIGNERS took their fight for a hepatitis C public inquiry to the courts yesterday, hoping that the Scottish Executive would be forced into a U-turn.
Scotsman Wed, 07 Mar 2007 01:35:47 GMT

Improving Quality Of Life For Patients With Cirrhosis
A study on patients with cirrhosis who had minimal hepatic encephalopathy (MHE), a condition in which behavioral, psychological and neurological changes are associated with advanced liver disease, found that cognitive function and health related quality-of-life improved when they took lactulose. Lactulose is a drug used to help eliminate toxins such as ammonia that are normally cleared by the liver.
Medicalnewstoday.com Tue, 06 Mar 2007 11:00:00 PDT

Model For Predicting Survival In Liver Patients Has Many Applications But Refining Will Continue
A review of the studies on the Model for End-Stage Liver Disease (MELD) found that it is an accurate predictor of survival of patients with a variety of liver diseases, is particularly useful in allocating organs for liver transplants, and can also be used to help determine the course of treatment in certain cases. However, it is possible to improve the accuracy of the model and efforts at refining will continue.
Medicalnewstoday.com Tue, 06 Mar 2007 05:00:00 PDT

HIV Drug Resistance Spurred By Widely Used Hepatitis B Drug
A Johns Hopkins study has proven false established medical practice that an antiretroviral drug widely used to treat hepatitis B liver infections was safe to use on its own in patients co-infected with HIV. Their findings demonstrate that treatment with entecavir leads to cross-resistance to other antiviral drugs used to treat the AIDS virus.
Medicalnewstoday.com Sun, 04 Mar 2007 20:00:00 PDT

Sweat May Pass On Hepatitis B In Contact Sports
Sweat may be another way to pass on hepatitis B infection during contact sports, suggests research published ahead of print in the British Journal of Sports Medicine.Hepatitis B virus attacks the liver and can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death.The research team analysed blood and sweat samples from 70 male Olympic wrestlers for evidence of hepatitis B infection (HBV).
Medicalnewstoday.com Sun, 04 Mar 2007 00:00:00 PDT

SEBIVO(R) (Telbivudine) Approved In China As New Treatment Option For Patients With Chronic Hepatitis B
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that SEBIVO(R) (telbivudine) has received approval from the Chinese State Food and Drug Administration (SFDA) as a once-a-day treatment, taken orally with or without food, for the treatment of chronic hepatitis B (CHB). CHB remains a significant global health care concern, particularly in China where it affects more than 100 million people(1-3) - representing about one-third of those infected worldwide.
Medicalnewstoday.com Sat, 03 Mar 2007 00:00:00 PDT

Genelabs Announces Publication In New England Journal Of Medicine Of Clinical Trial Results With Hepatitis E Virus Vaccine
Genelabs Technologies, Inc. (Nasdaq: GNLB) today announced publication of the results of a clinical trial with an investigational hepatitis E virus (HEV) vaccine in the March 1, 2007 issue of the New England Journal of Medicine. In an article entitled Safety and Efficacy of a Recombinant Hepatitis E Vaccine, the authors report that the investigational vaccine was found to be 95.
Medicalnewstoday.com Fri, 02 Mar 2007 00:00:00 PDT

Hepatitis sweat warning for contact sports
RUGBY players could be at risk of contracting hepatitis B through sweat, researchers said yesterday.
Scotsman Thu, 01 Mar 2007 00:31:11 GMT

Roddick reveals she has hepatitis C 'and it's a bit of a bummer'
THE Body Shop founder, Dame Anita Roddick, has revealed she is carrying the hepatitis C virus.
Scotsman Thu, 15 Feb 2007 00:21:36 GMT

Body Shop founder Roddick has Hepatitis C
BODY Shop founder Anita Roddick revealed today she is suffering from the disease Hepatitis C.
Scotsman Wed, 14 Feb 2007 14:52:41 GMT

Chef in HIV trial denies '200 lovers' claim
ITALIAN chef Giovanni Mola admitted in court yesterday that he had infected a woman with HIV and hepatitis C, but denied he was a "serial Romeo" who had bedded 200 women.
Scotsman Tue, 06 Feb 2007 00:08:13 GMT

New silent killer pulsing through drug users' veins
BACK in the 1980s, Scottish doctors found themselves at the centre of a storm. The eyes of the world fell on the heroin dens of Muirhouse, in Edinburgh, where the UK's first HIV epidemic among drug users was discovered.
Scotsman Mon, 22 Jan 2007 00:52:25 GMT

Lothians gets cash boost to fight hepatitis C
MORE than £550,000 is to be invested in the Lothians to help tackle rates of hepatitis C infections.
Scotsman Tue, 26 Sep 2006 10:47:36 GMT

New treatment for hepatitis C
THOUSANDS of patients in the early stages of infection from hepatitis C are set to benefit from new guidance issued to the NHS.
Scotsman Thu, 24 Aug 2006 01:02:57 GMT


Archive